Leukemia Articles A-Z
A person's CLL prognosis is an opinion as to the outcome of the disease. This section of the eMedTV library discusses the factors that affect a prognosis for someone with CLL and provides survival rates and other statistics.
According to CLL statistics, an estimated 10,020 people will be diagnosed with the cancer in 2006. This eMedTV segment discusses a variety of statistics concerning CLL, including death rates, survival rates, and lifetime risk figures.
Common CLL symptoms may include fever and infection, feeling very tired, and weight loss. This eMedTV article discusses common symptoms of CLL, which also include pain or fullness below the ribs and painless swelling of lymph nodes.
There are six stages of CLL (chronic lymphocytic leukemia) used to express the extent of the disease. This eMedTV Web page explores CLL treatment by stage, which ranges from watchful waiting to participating in clinical trials of new treatments.
Based on CML statistics, it's estimated that 4,500 people will be diagnosed with the disease in 2006. This eMedTV article offers a variety of statistics concerning chronic myeloid leukemia, including survival rates and age-at-diagnosis statistics.
CML symptoms may include fever, night sweats, feeling very tired, and weight loss. This part of the eMedTV archives describes possible chronic myelogenous leukemia (CML) symptoms, which are generally mild at first and progress gradually.
There is no staging system for chronic myelogenous leukemia (CML); therefore, this eMedTV article does not break down CML treatment by stage, but instead discusses treatment of CML based on the phase of the cancer.
A doctor may prescribe Cytoxan to treat various types of cancer (such as leukemia and breast cancer). This eMedTV resource lists other types of cancer that can be treated with Cytoxan, explains how the drug works, and offers dosing information.
It is generally recommended that you avoid breastfeeding while you are taking Cytoxan. This eMedTV page offers more information on Cytoxan and breastfeeding, and explains why breastfeeding women should not use the drug.